Home › NDC Lookup › RxCUI directory › RxCUI 824338

Darunavir 400 MG Oral Tablet — RxCUI 824338

RxNorm drug concept · Semantic clinical drug
RxCUI 824338 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI824338
Official nameDarunavir 400 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdarunavir (as darunavir ethanolate) 400 MG Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)117 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Darunavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats HIV-1 infection in adults and children 3 years and older. You take it with ritonavir and other HIV medicines. It works by blocking an enzyme the virus needs to mature.
  • Ritonavir boosts darunavir to levels high enough to work, and food helps your body absorb it. Without them, the medicine may not control the virus well. Please don't skip either on...
  • Why do I have to take it with ritonavir and food?
  • The most common are diarrhea, nausea, rash, headache, belly pain, and vomiting. Rash is often mild and may go away as you keep taking it. Call your doctor if the rash is severe or...
📖 Read our full Darunavir guide →

🕸️ Concept Web — How Darunavir 400 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Darunavir 400 MG Oral Tablet RxCUI 824338

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Darunavir 460132
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Darunavir Oral Tablet 643073
    • Darunavir Oral Product 1157184
    • Darunavir Pill 1157185
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Darunavir 400 MG 824337

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Darunavir 400 MG SCDC · 824337
  • Darunavir Oral Tablet SCDF · 643073
  • Darunavir Oral Product SCDG · 1157184
  • Darunavir Pill SCDG · 1157185

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 824338 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
31722-0567-60 60 TABLET, FILM COATED in 1 BOTTLE (31722-567-60) Darunavir Camber Pharmaceuticals, Inc. 2023-09-14
31722-0568-60 60 TABLET, FILM COATED in 1 BOTTLE (31722-568-60) Darunavir Camber Pharmaceuticals, Inc. 2023-09-14
Observed labelers: Camber Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.